FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
CBSN
Health and Human Services Secretary Robert F. Kennedy Jr. has asked Food and Drug Administration Commissioner Marty Makary "to review the latest data on mifepristone," raising questions about the drug commonly referred to as the abortion pill.
A spokesperson for the FDA confirmed the plans in a statement to CBS News Tuesday, but did not respond to questions about when the review is scheduled to start and what exactly it will be reviewing about the medication.
According to a letter published on social media Monday by Republican Sen. Josh Hawley of Missouri, Makary's review aims to closely monitor the drug's safety. But experts say concerns about its safety are misguided, fueled in part by a report from the Ethics and Public Policy Center, an advocacy group that promotes religious traditions and is funded by multiple right-wing organizations.
